Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review

The evidence for use of LEV as an alternative stage two AED in SE is limited. The higher efficacy reported in retrospective studies indicates possible publication bias, and caution is advised when the results of these retrospective studies are considered in clinical decision-making.